- Honorary Consultant in Medical Oncology
I Study the role of insulin-like growth factor (IGF) signalling in tumour biology, aiming to use this information to develop new ways to prevent and treat cancer.
Val's clinical interests are in prostate cancer and in testing the potential of novel signalling inhibitors to enhance sensitivity to conventional anti-cancer treatments.
She qualified as a doctor at Charing Cross Hospital Medical School and trained in Medical Oncology at the Royal Marsden Hospital London and Churchill Hospital Oxford. Following a PhD with Alan Ashworth at Chester Beatty Laboratories in London, her postdoctoral training was supported by MRC Clinician Scientist and Cancer Research UK Senior Clinical Fellowships.
Rieunier G. et al, (2019), Clin Cancer Res
Aleksic T. et al, (2018), Cancer Res, 78, 3497 - 3509
Earwaker P. et al, (2018), PLoS One, 13
Aleksic T. et al, (2017), Br J Cancer, 117, 1600 - 1606
Simpson A. et al, (2017), Target Oncol, 12, 571 - 597